M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, recommends shifts in policies that could expand federally qualified health centers.
M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, recommends shifts in policies that could expand federally qualified health centers.
Transcript
What policies do you think could expand the safety net role that federally qualified health centers play?
Thankfully, there has been bipartisan support and increasing funding and different programs and different tests to see how the health center program can grow and expand and better meet this need that persists, unfortunately. So, the community health center fund was the big one that came out of the Affordable Care Act and before that there was additional expansion and funding, they did capital health funding for health centers, then even before that before the recession there was expansion money for new access sites so I would say, continuing that additional funding which I believe congress just did support the continuation of the health center funding, which is fabulous.
Also thinking about how Medicaid expansion in states that didn’t expand it might affect some of these health centers because they do get reimbursed if they have an enhanced reimbursement for Medicaid. So, that does help them if their payer mix is a little more balanced. It helps them serve more uninsured patient population if they have more people with insurance to balance that out but they make it either way.
Then, there’s also been interesting funding out of CMS that providing demonstration projects to health centers to become patient centered medical homes, for example. There’s the advanced care primary practice demonstration. And some other quality improvement tests that there’s been funding for because health centers have been very under resourced and usually really understaffed. I worked in one for a very long time and people they are very creative and able to do a lot with very little money. But I think thinking about improving the quality and services they provide, providing access points where there is need and giving the opportunity to grow and meet, we know that demand is growing, see how they can meet that need best and that takes a little bit of funding and resources and nuance. Any support [Health Resources and Services Administration] could give or CMS can give through different reimbursement strategies and testing that out would be my recommendation.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More